Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Alternative Outcome Measures in Cost-Effectiveness Analysis: Three Applications Within Oncology.

PharmacoEconomics·2026
Same author

Economic Evaluation of Pre-emptive Pharmacogenetic Panel Testing versus No Genetic Testing in a Multi-ethnic Asian Population.

PharmacoEconomics·2026
Same author

Lowering the Barriers to the Appropriate Use of Individual-Level Simulation for Health Economic Evaluation.

PharmacoEconomics·2026
Same author

A Framework for Reliable, Transparent, and Reproducible Population-Adjusted Indirect Comparisons.

PharmacoEconomics·2025
Same author

Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease.

Orphanet journal of rare diseases·2024
Same author

Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. <i>Cancers</i> 2023, <i>15</i>, 1812.

Cancers·2023
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

One Dimensional Turing-Like Handshake Test for Motor Intelligence
14:05

One Dimensional Turing-Like Handshake Test for Motor Intelligence

Published on: December 15, 2010

No head-to-head trial? simulate the missing arms.

J Jaime Caro1, K Jack Ishak

  • 1Division of General Internal Medicine and Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. jaime.caro@mcgill.ca

Pharmacoeconomics
|September 14, 2010
PubMed
Summary
This summary is machine-generated.

Simulated treatment comparison (STC) creates virtual head-to-head trials when direct evidence is missing. This method informs healthcare decisions and economic models until real trial data become available.

More Related Videos

An Experiment Using Functional Near-Infrared Spectroscopy and Robot-Assisted Multi-Joint Pointing Movements of the Lower Limb
05:25

An Experiment Using Functional Near-Infrared Spectroscopy and Robot-Assisted Multi-Joint Pointing Movements of the Lower Limb

Published on: June 7, 2024

Application of a Dual Upper Limb Task-Oriented Robotic System for the Functional Recovery of the Upper Limb in Stroke Patients
05:28

Application of a Dual Upper Limb Task-Oriented Robotic System for the Functional Recovery of the Upper Limb in Stroke Patients

Published on: October 11, 2024

Related Experiment Videos

Last Updated: Jun 8, 2026

One Dimensional Turing-Like Handshake Test for Motor Intelligence
14:05

One Dimensional Turing-Like Handshake Test for Motor Intelligence

Published on: December 15, 2010

An Experiment Using Functional Near-Infrared Spectroscopy and Robot-Assisted Multi-Joint Pointing Movements of the Lower Limb
05:25

An Experiment Using Functional Near-Infrared Spectroscopy and Robot-Assisted Multi-Joint Pointing Movements of the Lower Limb

Published on: June 7, 2024

Application of a Dual Upper Limb Task-Oriented Robotic System for the Functional Recovery of the Upper Limb in Stroke Patients
05:28

Application of a Dual Upper Limb Task-Oriented Robotic System for the Functional Recovery of the Upper Limb in Stroke Patients

Published on: October 11, 2024

Area of Science:

  • Health economics
  • Clinical trial methodology
  • Comparative effectiveness research

Background:

  • Payer coverage decisions increasingly require evidence comparing new interventions against existing ones, not just placebo.
  • Head-to-head trials are the gold standard for comparative effectiveness but are rarely conducted.
  • Lack of direct comparative data hinders informed decision-making for healthcare interventions.

Purpose of the Study:

  • To introduce and describe the simulated treatment comparison (STC) methodology.
  • To demonstrate how STC can generate simulated head-to-head trial data from existing single-arm trials.
  • To highlight STC's utility in informing payers and economic models in the absence of direct comparative evidence.

Main Methods:

  • STC replicates an index trial's design, including patient enrollment, randomization, and follow-up, using predictive equations derived from the index trial data.
  • Separate comparator data are used to calibrate these equations, simulating the addition of 'missing arms' to the index trial.
  • The calibrated simulation estimates the outcomes that would have been observed in a direct head-to-head comparison.

Main Results:

  • The STC approach successfully generates simulated head-to-head trial results, addressing discrepancies between source trials.
  • It provides valuable inputs for health economic models, aiding decision-makers.
  • The method allows for the estimation of comparative effectiveness across diverse settings and populations.

Conclusions:

  • Simulated treatment comparison (STC) offers a robust method for deriving comparative effectiveness evidence when direct trial data are unavailable.
  • STC can inform healthcare policy and economic evaluations, bridging the gap until head-to-head trials are conducted.
  • This approach also serves as a platform for testing trial design features to optimize future head-to-head studies.